Reapplication of the Type IV Hypersensitivity Quantitative Risk Assessment to Assess Ingredients Used on Canines
McDermott A., Lorch G., Nash J., Kern P.
Narrative Review on Hair & Scalp, published in Vet Med Sci (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Vet Med Sci (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40536915
- PMCID
- PMC12178314
- DOI
- 10.1002/vms3.70463
Abstract (original English)
A quantitative risk assessment (QRA) framework to assess the risk for the induction of human skin sensitization from exposure to contact allergens has been successfully developed and applied. So far, the QRA has not been applied in a canine risk assessment for establishing concentration limits of ingredients with Type IV hypersensitivity potential. Outlining this risk assessment is critical, as shampoos are known to cause allergic contact dermatitis (ACD) in canines. Additionally, humans have developed ACD after washing their dogs with dog shampoo. To address this gap, we conducted a thorough literature review on canine Type IV hypersensitivity and identified potential differences which might demand an adaptation of the QRA. We summarize data from the literature demonstrating that all four key events (KE) in the skin sensitization adverse outcome pathway (AOP) are present in dogs as they are in humans, guinea pigs, and mice. The hazard potential of sensitizers for canines is compared with the established sensitization QRA framework for humans. The limited collective evidence suggests that dogs are not more susceptible to sensitizers than humans; therefore, safety-defined concentration limits from Type IV hypersensitivity risk assessments for humans can be re-applied to canines so long as their unique exposure considerations are factored in. Using the principles in this review,
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia.
Systematic Review with a reported sample of 724 on Hair Loss, Hair Regeneration, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 724
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
DKK3-CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia
Meta-analysis on Hair Loss, Hair Regeneration, published in Theranostics (2026) — summary generated from the PubMed abstract.
- 2026
Theranostics - Level ASystematic ReviewEurope PMC
Autolougous platelet concentrates in esthetic medicine
Systematic Review on Scar, Skin Aging, Facial Rejuvenation, Hair Regeneration, published in Periodontol 2000 (2025) — summary generated from the PubMed abstract.
- 2025
Periodontol 200016 citations - Level ASystematic ReviewPubMed
The Potency of Adipose-Derived Mesenchymal Stem Cells to Increase Ovarian Function in Primary Ovarian Insufficiency: A Systematic Review of in vivo Studies.
Systematic Review with a reported sample of 5 on Hair & Scalp, published in Gynecol Obstet Invest (2025) — summary generated from the PubMed abstract.
- 2025
- n = 5
Gynecol Obstet Invest - Level ASystematic ReviewPubMed
Efficacy and safety of platelet-rich plasma therapy in systemic sclerosis and localized scleroderma; a systematic review.
Systematic Review on Hair Regeneration, published in Arch Dermatol Res (2025) — summary generated from the PubMed abstract.
- 2025
Arch Dermatol Res2 citations